Emergence 2026: Life Science Investor Day Presentation

Written By Michelle Long

Arovella CEO and MD, Dr Michael Baker, presented at the Life Science Investor Day as part of Emergence 2026 in Sydney on Wednesday February 18th.

Dr Baker shared how Arovella is advancing oncology therapies with innovative off-the-shelf CAR-iNKT cell technology for patients worldwide.

View the presentation (pdf)

 
Michelle Long
Previous

TGA clears ALA-101 trial under CTN scheme
Next

Board Changes